^
    CANCER:

    Uterine Corpus Leiomyosarcoma





    Show legend
    Group by Gene:
    Include preclinical:

    0
    Progesterone receptor agonist
    megestrol
    1
    Multi-tyrosine kinase inhibitor
    pazopanib
    2
    Aromatase inhibitor
    Aromatase inhibitor
    anastrozole
    3
    PARP inhibitor
    PARP inhibitor
    olaparib
    4
    PD-L1 inhibitor, PARP inhibitor
    avelumab + talazoparib
    5
    CD70-targeted antibody-drug conjugate
    ARX305
    6
    AKT inhibitor
    capivasertib
    7
    ALK inhibitor
    alectinib
    crizotinib
    8
    DNA synthesis inhibitor, PARP inhibitor
    olaparib + temozolomide
    9
    ROS1 inhibitor, ALK inhibitor
    lorlatinib
    10
    ATR inhibitor
    BAY 1895344
    No biomarker
    PGR positive
    ER positive
    FN1-ALK fusion
    PALB2 deletion
    AKT1 E17K
    CD70 expression
    ER positive + PGR positive
    RAD51B deletion
    BRCA2 mutation
    BRCA1 mutation
    HRD
    ATRX mutation